These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


150 related items for PubMed ID: 301007

  • 1. Comparative acitivity of ampicillin and cefuroxime against three types of Haemophilus influenzae.
    Sykes RB, Griffiths A, Ryan DM.
    Antimicrob Agents Chemother; 1977 Apr; 11(4):599-604. PubMed ID: 301007
    [Abstract] [Full Text] [Related]

  • 2. Antimicrobial activities and susceptibility testing considerations of ampicillin, cephalothin, cefaclor, and cefuroxime against invasive isolates of Haemophilus influenzae.
    Shelton MM, Welch DF.
    Chemotherapy; 1989 Apr; 35(2):88-94. PubMed ID: 2788068
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of second and third generation cephalosporins against ampicillin susceptible and resistant haemophilus influenzae.
    Burns JL, Wong K, Smith AL.
    Infection; 1988 Apr; 16(5):293-6. PubMed ID: 3265130
    [Abstract] [Full Text] [Related]

  • 4. Susceptibilities of beta-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acid.
    Barry AL, Fuchs PC, Pfaller MA.
    Antimicrob Agents Chemother; 1993 Jan; 37(1):14-8. PubMed ID: 8431012
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vitro activities of cefotaxime and moxalactam (LY127935) against Haemophilus influenzae.
    Jorgensen JH, Crawford SA, Alexander GA.
    Antimicrob Agents Chemother; 1980 Mar; 17(3):516-7. PubMed ID: 6252832
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of disk diffusion methods to detect low-level β-lactamase-negative ampicillin-resistant Haemophilus influenzae.
    Nørskov-Lauritsen N, Ridderberg W, Erikstrup LT, Fuursted K.
    APMIS; 2011 Jun; 119(6):385-92. PubMed ID: 21569097
    [Abstract] [Full Text] [Related]

  • 11. Are beta-lactam breakpoints adequate to define non-susceptibility for all Haemophilus influenzae resistance phenotypes from a pharmacodynamic point of view?
    Alou L, Giménez MJ, Sevillano D, Aguilar L, González N, Echeverría O, Torrico M, Coronel P, Prieto J.
    J Antimicrob Chemother; 2007 Apr; 59(4):652-7. PubMed ID: 17341471
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Increasing prevalence of ampicillin- resistant, non-beta-lactamase-producing strains of Haemophilus influenzae in children in Japan.
    Seki H, Kasahara Y, Ohta K, Saikawa Y, Sumita R, Yachie A, Fujita S, Koizumi S.
    Chemotherapy; 1999 Apr; 45(1):15-21. PubMed ID: 9876205
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Susceptibility of Haemophilus influenzae isolates with known resistance mechanisms to five cephalosporins.
    Yeo SF, Chiew YF, Fung CP.
    Chemotherapy; 1996 Apr; 42(2):85-9. PubMed ID: 8697893
    [Abstract] [Full Text] [Related]

  • 19. Influences of media and inocula on the in vitro susceptibility of Haemophilus influenzae to co-trimoxazole, ampicillin, penicillin, and chloramphenicol.
    Marks MI, Weinmaster G.
    Antimicrob Agents Chemother; 1975 Dec; 8(6):657-63. PubMed ID: 1082293
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.